304 related articles for article (PubMed ID: 24196788)
61. Human leukocyte antigen-G in gynaecological tumours.
Guo X; Zhang J; Shang J; Cheng Y; Tian S; Yao Y
Int J Immunogenet; 2023 Aug; 50(4):163-176. PubMed ID: 37415092
[TBL] [Abstract][Full Text] [Related]
62. Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer.
Michelakos T; Kontos F; Kurokawa T; Cai L; Sadagopan A; Krijgsman D; Weichert W; Durrant LG; Kuppen PJK; R Ferrone C; Ferrone S
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35277460
[TBL] [Abstract][Full Text] [Related]
63. HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases.
Swets M; König MH; Zaalberg A; Dekker-Ensink NG; Gelderblom H; van de Velde CJ; van den Elsen PJ; Kuppen PJ
Hum Immunol; 2016 Sep; 77(9):773-9. PubMed ID: 26968946
[TBL] [Abstract][Full Text] [Related]
64. Clinical and biological significance of HLA-G expression in ovarian cancer.
Sheu JJ; Shih IeM
Semin Cancer Biol; 2007 Dec; 17(6):436-43. PubMed ID: 17681474
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of HLA-G, HLA-E, and PD-L1 proteins in oral osteosarcomas.
Costa Arantes DA; Gonçalves AS; Jham BC; Duarte ECB; de Paula ÉC; de Paula HM; Mendonça EF; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jun; 123(6):e188-e196. PubMed ID: 28159587
[TBL] [Abstract][Full Text] [Related]
66. Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape.
Bernal M; García-Alcalde F; Concha A; Cano C; Blanco A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2012 Jun; 61(6):803-16. PubMed ID: 22072317
[TBL] [Abstract][Full Text] [Related]
67. Antigen presentation by class I major histocompatibility complex molecules: a context for thinking about HLA-G.
Parham P
Am J Reprod Immunol; 1995 Jul; 34(1):10-9. PubMed ID: 7576126
[No Abstract] [Full Text] [Related]
68. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Wischhusen J; Waschbisch A; Wiendl H
Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
[TBL] [Abstract][Full Text] [Related]
69. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.
Fellerhoff B; Gu S; Laumbacher B; Nerlich AG; Weiss EH; Glas J; Kopp R; Johnson JP; Wank R
Cancer Res; 2011 Dec; 71(23):7145-54. PubMed ID: 22037870
[TBL] [Abstract][Full Text] [Related]
70. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
Dierssen JW; de Miranda NF; Ferrone S; van Puijenbroek M; Cornelisse CJ; Fleuren GJ; van Wezel T; Morreau H
BMC Cancer; 2007 Feb; 7():33. PubMed ID: 17316446
[TBL] [Abstract][Full Text] [Related]
71. Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.
Matsushita H; Hasegawa K; Oda K; Yamamoto S; Asada K; Karasaki T; Yabuno A; Nishijima A; Nejo T; Kobayashi Y; Sato S; Ikeda Y; Miyai M; Takahashi Y; Yamaguchi R; Fujiwara K; Aburatani H; Kakimi K
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461346
[TBL] [Abstract][Full Text] [Related]
72. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Amiot L; Ferrone S; Grosse-Wilde H; Seliger B
Cell Mol Life Sci; 2011 Feb; 68(3):417-31. PubMed ID: 21063893
[TBL] [Abstract][Full Text] [Related]
73. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
[TBL] [Abstract][Full Text] [Related]
74. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
75. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
76. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
[TBL] [Abstract][Full Text] [Related]
77. NK Cell Infiltrates and HLA Class I Expression in Primary HER2
Muntasell A; Rojo F; Servitja S; Rubio-Perez C; Cabo M; Tamborero D; Costa-García M; Martínez-Garcia M; Menéndez S; Vazquez I; Lluch A; Gonzalez-Perez A; Rovira A; López-Botet M; Albanell J
Clin Cancer Res; 2019 Mar; 25(5):1535-1545. PubMed ID: 30523021
[TBL] [Abstract][Full Text] [Related]
78. Loss of colonic HLA antigens in familial adenomatous polyposis.
Tsioulias G; Godwin TA; Goldstein MF; McDougall CJ; Ngoi SS; DeCosse JJ; Rigas B
Cancer Res; 1992 Jun; 52(12):3449-52. PubMed ID: 1317751
[TBL] [Abstract][Full Text] [Related]
79. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
80. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
